5
Omega Laboratories
524406 BSE
Omega Laboratories
Healthcare BSE: 524406 Pharmaceuticals & Biotechnology
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
Net Income Growth
-5%
Quarterly Results
| Particulars | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.66 | 30.03 | 7.09 | 49.63 | 8.11 | 49.71 | 19.28 | 48.78 | 22.29 |
| Expenses | 4.41 | 28.46 | 6.63 | 47.75 | 7.2 | 46.7 | 16.44 | 46.51 | 20.41 |
| Operating Profit | 0.25 | 1.57 | 0.46 | 1.88 | 0.91 | 3.01 | 2.84 | 2.27 | 1.88 |
| OPM % | 5.36% | 5.23% | 6.49% | 3.79% | 11.22% | 6.06% | 14.73% | 4.65% | 8.43% |
| Other Income | 0 | 0.05 | 0.05 | 0.04 | 0 | 0.07 | 0.03 | 0.08 | 2.58 |
| Interest | 0.05 | 0.06 | 0.15 | 0.19 | 0.4 | 0.54 | 0.75 | 0.74 | 0.75 |
| Depreciation | 0 | 0 | 0 | 0 | 0.06 | 0.05 | 0.06 | 0.08 | 0.13 |
| PBT | 0.2 | 1.56 | 0.36 | 1.73 | 0.45 | 2.49 | 2.06 | 1.53 | 3.58 |
| Tax % | 25% | 25.64% | 25% | 42.2% | 26.67% | 28.11% | 26.7% | 28.76% | 17.88% |
| Net Profit | 0.15 | 1.15 | 0.27 | 1 | 0.33 | 1.79 | 1.5 | 1.08 | 2.94 |
| EPS in Rs | 0.15 | 0.75 | 0.18 | 0.65 | 0.21 | 1.16 | 0.97 | 0.7 | 1.91 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 |
|---|---|---|
| Sales | 0 | 0 |
| Expenses | 0.07 | 0.04 |
| Operating Profit | -0.07 | -0.04 |
| Other Income | 0.13 | 0.01 |
| Interest | 0 | 0 |
| Depreciation | 0.5 | 0.43 |
| PBT | -0.44 | -0.46 |
| Tax % | 0% | 0% |
| Net Profit | -0.44 | -0.46 |
| Div. Payout % | 0% | 0% |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 |
|---|---|---|
| Equity Capital | 6.97 | 6.97 |
| Reserves | -15.84 | -16.3 |
| Borrowings | 14.6 | 14.6 |
| Other Liabilities | 0.08 | 0.08 |
| Total Liabilities | 5.81 | 5.35 |
| Fixed Assets | 3.67 | 3.24 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 2.14 | 2.11 |
| Total Assets | 5.81 | 5.35 |
Cash Flow
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Operating | 0.09 | 0.1 | -0.1 | -1.45 | 0.47 | -9.07 | 2.06 |
| Investing | 0 | 0 | -0.03 | -5.16 | -7.86 | -1.05 | -11.45 |
| Financing | -0.1 | -0.1 | 0.13 | 7.03 | 7.18 | 10.51 | 9.33 |
| Net Cash Flow | 0 | -0.01 | 0.01 | 0.42 | -0.2 | 0.39 | -0.06 |
Ratios
| Particulars | Mar 2006 | Mar 2007 |
|---|---|---|
| Inventory Days | 0 | — |
| ROCE % | — | -8.36% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Omega Laboratories insights
24 extracted metrics + investor summaries across FY06–FY25.
Documents
1
Amendment to AOA/MOA
2 March 2026 - 02.03.2026: Shareholders approved MOA amendment adding metals, steel, minerals trading/manufacturing via postal ballot. 2 March 2026 - 02.03.2026: Shareholders approved MOA amendment adding metals, steel, minerals trading/manufacturing via postal ballot.
2
Shareholders meeting
2 March 2026 - Special resolution to alter MOA passed; 99,79,611 votes (100% of votes cast) on Feb 27, 2026. 2 March 2026 - Special resolution to alter MOA passed; 99,79,611 votes (100% of votes cast) on Feb 27, 2026.
3
Reply to Clarification- Financial results
4 February 2026 - Clarifies omission of Sep 2024 comparative cash flow figures for H1 ended 30 Sep 2025; corrected statement enclosed. 4 February 2026 - Clarifies omission of Sep 2024 comparative cash flow figures for H1 ended 30 Sep 2025; corrected statement enclosed.
4
Shareholders meeting
28 January 2026 - Postal ballot (e-vote 29 Jan–27 Feb 2026) to amend MOA to add mining and steel trading objects. 28 January 2026 - Postal ballot (e-vote 29 Jan–27 Feb 2026) to amend MOA to add mining and steel trading objects.
5
Copy of Newspaper Publication
28 January 2026 - Published advertisement on 28 Jan 2026 for company postal ballot notice. 28 January 2026 - Published advertisement on 28 Jan 2026 for company postal ballot notice.
Frequently Asked Questions about Omega Laboratories
Where is Omega Laboratories Ltd (524406) listed?
Omega Laboratories Ltd trades under code 524406 on the BSE.
Which sector does Omega Laboratories Ltd belong to?
Omega Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
Company Information
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524406.md for Omega Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.